Business Context and Reporting Period
This Form 8-K is a current report filed by LeMaitre Vascular, Inc. on December 22, 2006. The filing addresses Item 5.02 regarding compensatory arrangements for certain officers under the Company's 2006 Stock Option and Incentive Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on equity compensation awards rather than financial performance metrics.
Material Changes and Compensation Awards
On December 22, 2006, the Compensation Committee approved two types of equity awards for four officers:
Common Stock Awards (Non-Vesting)
- David B. Roberts (CFO): 11,806 shares
- Peter R. Gebauer (President, International Operations): 13,255 shares
- Kevin D. Kelly (VP, North American Sales): 1,363 shares
- Trent G. Kamke (SVP, Operations): 3,120 shares
Restricted Stock Units (RSUs)
These awards vest in equal installments over a three-year period based on continued service:
- David B. Roberts (CFO): 10,000 shares underlying RSUs
- Peter R. Gebauer (President, International Operations): 10,000 shares underlying RSUs
- Kevin D. Kelly (VP, North American Sales): 5,000 shares underlying RSUs
- Trent G. Kamke (SVP, Operations): 10,000 shares underlying RSUs
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total number of shares issued immediately (non-vesting) versus those subject to the three-year vesting schedule.
- Confirm the impact of these awards on the company's total authorized share count under the 2006 Stock Option and Incentive Plan.
- Review the attached Exhibit 99.1 (Form of Restricted Stock Unit Award Agreement) for specific forfeiture conditions or performance metrics not detailed in the summary.